Is There a 4 mg Ozempic Pen? Understanding Ozempic Dosing and Formulations

Last reviewed: July 3, 2026

Last updated: July 3, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Ozempic (semaglutide) is available in pre-filled pens with set dose increments: 0.25 mg, 0.5 mg, 1 mg, and 2 mg. Many patients ask whether a 4 mg pen exists—it doesn't from the brand manufacturer. However, compounded semaglutide injections from PlexusDx can be customized to support progressive dose escalation beyond standard commercial formulations.

What Doses Does Ozempic Come In?

Ozempic pens are manufactured in four standardized strengths: 0.25 mg, 0.5 mg, 1 mg, and 2 mg per injection. The 2 mg dose represents the maximum dose available in the branded product line. Each pen delivers a fixed amount, and users must switch pens to increase their dose—there is no 3 mg or 4 mg Ozempic pen offered by the manufacturer.

The standard titration protocol starts with 0.25 mg once weekly, increasing by 0.25 mg increments every four weeks until reaching a therapeutic dose or maximum tolerance. Most patients stabilize between 1 mg and 2 mg weekly, though some may require higher amounts for sustained weight loss or glycemic control. Clinical trials show that dose adjustments are gradual and individualized based on tolerability and response.

Why Compounded Semaglutide Offers More Flexibility

Compounded semaglutide from licensed 503A pharmacies can be prepared at custom concentrations to support dosing beyond the 2 mg commercial ceiling. This flexibility allows patients and providers to escalate therapy incrementally without the limitations of pre-filled pens. PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with consistent pricing regardless of dose—your dose may need to go up, but your price won't.

Compounding also enables patients who need more frequent adjustments or who respond better to personalized concentrations to receive treatment tailored to their metabolic profile. Unlike brand-name pens, compounded formulations do not require insurance approval or membership fees, making them accessible across all 50 states and eligible for HSA and FSA funds.

How Dose Escalation Works in Weight Loss Therapy

Dose escalation in semaglutide therapy follows a structured progression designed to minimize gastrointestinal side effects while building tolerance. Typical protocols begin at 0.25 mg and advance by 0.25 mg or 0.5 mg increments based on clinical response and patient comfort over 4–8 week intervals. The goal is to find the minimum effective dose that produces meaningful weight loss while remaining tolerable long-term.

The PlexusDx Precision Peptide Genetic Test reports on variants that relate to GLP-1 and related signaling pathways. It does not predict your response to Ozempic or determine your dose; it offers pathway-level context for a conversation with your provider. Genetics is a guide, not a guarantee.

PlexusDx Compounded Semaglutide vs. Brand-Name Ozempic

PlexusDx compounded semaglutide injection is manufactured by licensed 503A compounding pharmacies and meets USP standards for sterility, potency, and purity. Unlike branded Ozempic, compounded formulations can be dosed flexibly and adjusted without pen switching, offering convenience and cost predictability. The pricing model is flat—starting at $149 per month across all commitment tiers—so patients never pay more as their therapeutic dose increases.

Both formulations contain the same active pharmaceutical ingredient (semaglutide), but compounded versions eliminate insurance requirements, prior authorization delays, and formulary restrictions. PlexusDx serves all 50 states, accepts HSA and FSA payments, and includes optional genetic testing to personalize therapy selection. Patients can add the Precision Peptide Genetic Test for $298 to understand their genetic predisposition to GLP-1 responsiveness and guide long-term dosing strategy.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test ($298) to personalize your protocol from day one.

Frequently Asked Questions

Is there a 4 mg Ozempic pen available?

No, Ozempic pens max out at 2 mg. Compounded semaglutide from PlexusDx can support higher custom doses if needed, with consistent pricing that never increases with dose escalation.

What dose of semaglutide do most people need for weight loss?

Most patients see significant results between 1 mg and 2 mg weekly, though optimal dose varies by individual metabolism and genetic factors. Clinical trials show 1.5–2.4 mg weekly produces average weight losses of 10–15% of body weight over 68 weeks.

How much does PlexusDx compounded semaglutide cost?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) with no additional charge regardless of dose level. It's available in all 50 states, requires no insurance, and is eligible for HSA and FSA accounts.

Can I get higher doses with compounded semaglutide than brand-name Ozempic?

Yes, compounded semaglutide can be customized beyond the 2 mg Ozempic ceiling if clinically indicated. PlexusDx works with licensed 503A compounding pharmacies to prepare personalized concentrations without increasing your monthly cost.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR (rs1800437)) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Wegovy 025 Mg 05 Ml Pen
• Ozempic Dosing
• Lifemd Ozempic
• Eden Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.